Ryckwaert Frédérique, Boccara Gilles, Frappier Jean-Marc, Colson Pascal H
Department of Anaesthesiology and Intensive Care, Hopital Arnaud de Villeneuve, 34295 Montpellier, France.
Crit Care Med. 2002 Jul;30(7):1495-8. doi: 10.1097/00003246-200207000-00016.
To evaluate the incidence and prognosis of a moderate increase in serum creatinine early after cardiac surgery.
Retrospective clinical study.
Surgical intensive care unit in a university hospital.
Five hundred and ninety-one consecutive adult patients operated on for cardiac surgery during 1 year.
Plasma creatinine was measured systematically before and during the first 3 days after surgery. Comorbid events were assessed as organ dysfunction (cardiac, pulmonary, hematologic, and neurologic), allowing us to calculate for each patient a dysfunction score (0-5).
Postoperative plasma creatinine increased by > or =20% in 15.6% of patients; eight of these required dialysis. A 20% increase in plasma creatinine was associated with other organ dysfunction in 79.3% of patients. Overall mortality rate was 2.7% and increased with the dysfunction score (17.7% for a dysfunction score > or =3). Mortality rate was 12.0% for patients who had 20% increased plasma creatinine with other organ dysfunction but was 0% for patients without other organ dysfunction. A logistic regression analysis revealed that the most important prognostic factors of death were cardiac dysfunction (odds ratio, 8.5; 95% confidence interval, 2.2-32.5) and the association of renal dysfunction and hematologic dysfunction (odds ratio = 12.0; 95% confidence interval, 3.9-37.2). Mean intensive care unit stay of patients with increased plasma creatinine was significantly longer (8.1 +/- 5.6 vs. 4.3 +/- 1.4 days, p <.01) and increased significantly with the dysfunction score (p <.01). Patients with isolated increased plasma creatinine had a significantly longer stay in the intensive care unit than patients without any organ dysfunction (4.6 +/- 1.4 vs. 3.9 +/- 0.9, p <.01).
Our results suggest that a postoperative 20% increase in plasma creatinine after cardiac surgery is not rare and has a significant impact on postoperative outcome, mainly when multiple organ dysfunction occurs. Any preoperative reduced renal reserve or perioperative renal ischemia increases the renal risk.
评估心脏手术后早期血清肌酐中度升高的发生率及预后。
回顾性临床研究。
一所大学医院的外科重症监护病房。
连续1年内接受心脏手术的591例成年患者。
在手术前及术后前3天系统测量血浆肌酐。将合并症事件评估为器官功能障碍(心脏、肺、血液及神经方面),据此可为每位患者计算功能障碍评分(0 - 5分)。
15.6%的患者术后血浆肌酐升高≥20%;其中8例需要透析。血浆肌酐升高20%的患者中,79.3%伴有其他器官功能障碍。总体死亡率为2.7%,且随功能障碍评分增加而升高(功能障碍评分≥3分时为17.7%)。血浆肌酐升高20%且伴有其他器官功能障碍的患者死亡率为12.0%,而无其他器官功能障碍的患者死亡率为0%。逻辑回归分析显示,死亡的最重要预后因素是心脏功能障碍(比值比,8.5;95%置信区间,2.2 - 32.5)以及肾功能障碍与血液功能障碍的联合(比值比 = 12.0;95%置信区间,3.9 - 37.2)。血浆肌酐升高患者的平均重症监护病房住院时间显著更长(8.1±5.6天对4.3±1.4天,p <.01),且随功能障碍评分显著增加(p <.01)。单纯血浆肌酐升高的患者在重症监护病房的住院时间显著长于无任何器官功能障碍的患者(4.6±1.4天对3.9±0.9天,p <.01)。
我们的结果表明,心脏手术后血浆肌酐术后升高20%并不罕见,且对术后结局有显著影响,主要是在发生多器官功能障碍时。任何术前肾储备降低或围手术期肾缺血都会增加肾脏风险。